lilly
Lilly set to acquire Alnara Pharmaceuticals
July 5, 2010Research and Development, Sales and Marketing Alnara, Liprotamase, cystic fibrosis, enzyme replacement therapy, lilly
Lilly is to acquire US-based biotech firm Alnara and will take hold of its lead product Liprotamase for pancreatic enzyme …
Lilly faces substantial costs from US health reform
April 20, 2010Sales and Marketing 2010 financials, Obama, lilly
Lilly expects to lose up to $485 million this year as a direct result of the US healthcare reforms, but …
Lilly expands trial supply deal with Thermo
March 31, 2010Manufacturing and Production, Research and Development Thermo Fisher Scientifitic, lilly
Eli Lilly has expanded a clinical trial materials supply agreement with Thermo Fisher Scientific in yet another deal that sees …
Rooftop raiders steal $76m of Lilly products
March 18, 2010Manufacturing and Production, Sales and Marketing lilly, supply chain, theft
Thieves have made off with $75 million-worth of central nervous system, cardiovascular and cancer drugs from an Eli Lilly distribution …
Lilly acquires rights to testosterone treatment
March 16, 2010Sales and Marketing Acrux, hormone, lilly, male health
Lilly have entered into a worldwide licensing agreement with Australian-based Acrux for Axiron, an experimental under-arm testosterone applicator.The treatment is …
Alimta recommended as maintenance therapy
March 1, 2010Sales and Marketing Alimta, Cancer, NSCLC, lilly
NICE has recommended Alimta as a maintenance treatment for people with locally advanced or metastatic non-small cell lung cancer. Patients …
Failings at Lilly Humalog plant catch FDA’s eye
February 26, 2010Manufacturing and Production Humalog, lilly
Eli Lilly has been sent a warning letter about a production facility in Puerto Rico, which says the company failed …
Lilly UK appoints Ramona Sequeira managing director
February 23, 2010Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing
Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …
Lilly signs diabetes deal with Alizé Pharma
February 2, 2010Research and Development Alize, diabetes, lilly, type II
Lilly has signed a new research and licensing deal with Lyon-based Alizé Pharma to develop Alizé’s AZP-01 programme, focused on …
Healthy growth for Lilly but Effient doubts raised
February 1, 2010Sales and Marketing 2009 financials, lilly
Lilly’s revenues for the full year rose 7% in 2009, thanks to a growth in sales of Zyprexa, the flagship …
University of Cambridge joins Lilly’s open innovation group
January 20, 2010Research and Development Cambridge University, OIDD, University of Cambridge, lilly
The University of Cambridge is to join Eli Lilly’s ‘Open Innovation Drug Discovery’ project. Lilly first launched its online portal …
Evonik completes handover of Tippecanoe from Lilly
January 13, 2010Manufacturing and Production API, Evonik, lilly
Germany’s Evonik Industries has started up production of active pharmaceutical ingredients (APIs) at the Tippecanoe Laboratories facility acquired from Eli …
Lilly extends remit for finance chief Derica Rice
January 5, 2010Sales and Marketing appointment, lilly, sales and marketing
Lilly’s senior vice president and chief financial officer Derica Rice has taken on an expanded role. He becomes executive vice …
Dr Jan Lundberg to succeed Dr Steven Paul as head of Lilly Research Laboratories
November 27, 2009Research and Development AstraZeneca, appointment, appt, lilly, research and development
Dr Jan Lundberg has been appointed executive VP, science and technology, and president of Lilly Research Laboratories.He will succeed Dr …
Lilly finds buyer for threatened manufacturing unit
October 16, 2009Manufacturing and Production Evonik, lilly
Lilly has found a buyer for its manufacturing facility Tippecanoe Laboratories in Indiana, USA, which had been under threat of …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
